Products for Research Use Only
RegisterLogin

Regorafenib

CAT: 0013-GTR19178094-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19178094-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Regorafenib is an orally bioavailable, multi-targeted tyrosine kinase inhibitor active against key oncogenic and angiogenic receptors including RET, VEGFRs, and PDGFRβ. It exhibits potent antitumor and anti-angiogenic effects, validated in both in vitro assays and in vivo models of colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma.
CAS Number
755037-03-7
Product Name Alternative
BAY 73-4506
Field of Research
Cardiovascular Research
Purity
>98%
Bioactivity
Multi-kinase inhibitor; PDGF, VEGF etc
Form
Powder
Solubility
Soluble in DMSO up to 50 mg/ml
Smiles
CNC (=O) c1cc (Oc2ccc (NC (=O) Nc3ccc (Cl) c (c3) C (F) (F) F) c (F) c2) ccn1
Molecular Formula
C21H15ClF4N4O3
Molecular Weight
482.8
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[4-[[[[4-Chloro-3- (trifluoromethyl) phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide

Alternative Products

CatalogName
A8236-50Regorafenib

Popular Products